醫師代碼 :15081
專 長
- 老年排尿障礙、尿失禁、夜尿症
- 小兒泌尿、包皮手術、隱睪症、精索靜脈曲張
- 疝氣微創手術
- 前列腺肥大微創手術
- 尿路結石內視鏡微創治療、軟式輸尿管鏡
- 泌尿腫瘤
- 性功能障礙、男性更年期
現 職
- 佛教慈濟醫療財團法人花蓮慈濟醫院泌尿部 神經性泌尿科 主任
- 教育部部定助理教授
- 慈濟大學醫學系專任助理教授
學 歷
- 中國醫藥大學醫學系
經 歷
- 佛教慈濟醫療財團法人花蓮慈濟醫院 泌尿部 主治醫師
- 佛教慈濟醫療財團法人花蓮慈濟醫院 泌尿科臨床研究醫師
- 台大醫院泌尿部住院總醫師
- 台大醫院泌尿部住院醫師
簡易介紹
- 台灣泌尿科醫學會專科醫師
- 台灣尿失禁防治協會會員
- 台灣男性醫學會會員
- 台灣泌尿科醫學會資訊及線上教育委員會委員
- 台灣泌尿科醫學會小兒泌尿學委員會委員
- 台灣泌尿科醫學會專科醫師出題委員
發表論文
- Chen SF, Kuo HC.Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most? Toxins (Basel). 2023 Jan 17;15(2):8
- Chen SF, Kuo HC. Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan.Int Urol Nephrol. 2023 Nov 30. doi: 10.1007/s11255-023-03884-8.
- Chen SF, Lee YK, Kuo HC. Satisfaction with Urinary Incontinence Treatments in Patients with Chronic Spinal Cord Injury J Clin Med. 2022 Oct; 11(19): 5864
- Chen SF, Jiang YH, Chang JF, Kuo HC. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury. Toxins (Basel). 2022 Jan; 14(1): 35.
- Chen SF, Chuang YC, Wang CC, Liao CH, Kuo HC. Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system Disorders-A cohort study.J Formos Med Assoc. 2022 Oct;121(10):2101-2108.
-
Chen SF, Peng CH, Kuo HC. Will detrusor acontractility recover after medical or surgical treatment? A longitudinal long-term urodynamic follow-up
Neurourol Urodyn. 2021 Jan;40(1):228-236.doi: 10.1002/nau.24540. Epub 2020 Oct 14. - Jiang YH, Lee CL, Chen SF, Kuo HC. Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women.Toxins (Basel). 2021 May 19;13(5):362. doi: 10.3390/toxins13050362.PMID: 34069448
- Jiang YH, Chen SF, Kuo HC. Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction.Int Neurourol J. 2020 Dec;24(4):301-312. doi: 10.5213/inj.2040354.177. Epub 2020 Dec 31.
- Chen SF, Lee CL, Kuo HC. Change of Detrusor Contractility in Patients with and without Bladder Outlet Obstruction at Ten or More Years of follow-up. Scientific Reports. 2019 Dec 11;9(1):18887. doi: 10.1038/s41598-019-55386-2.
- Chen SF, Kuo HC. Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury? Tzu Chi Med J. 2020 Jul 29;33(2):101-107. doi: 10.4103/tcmj.tcmj_77_20. eCollection 2021 Apr-Jun.
- Chen SF, Lee CL, Kuo HC. Changes in sensory proteins in the bladder urothelium of patients with chronic kidney disease and end-stage renal disease.Low Urin Tract Symptoms. 2019 Apr;11(2):O202-O208. doi: 10.1111/luts.12240. Epub 2018 Sep 9.
- Chen SF, Jiang YH, Kuo HC. Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury. J Formos Med Assoc. 2018 Feb 23. pii: S0929-6646(17)30867-7. doi: 10.1016/j.jfma.2018.02.002.
- Chen SF, Kuo HC.Therapeutic efficacy of low-dose (25 mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseases.Low Urin Tract Symptoms. 2018 Jan 30. doi: 10.1111/luts.12215.
- Chen SF, Jiang YH, Kuo HC. (2017, Oct) Urinary biomarkers in patients with detrusor underactivity with and without bladder function recovery.Int Urol Nephrol. 2017 Oct;49(10):1763-1770. doi: 10.1007/s11255-017-1666-z.
- Chen SF, Chang CH, Kuo HC Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder. Toxins (Basel).2016 May 30;8(6).
- Chen SF, Chang CH, Kuo HC Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment. Spinal Cord.2016 Oct;54(10):889-894
- Chen SF, Kuo HC Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity J Formos Med Assoc.2015 Jul;114(7):583-9
-
Liao CH, Chen SF, Kuo HC. Different number of intravesical onabotulinumtoxinA injections for patients with refractory detrusor overactivity do not affect treatment outcome: A prospective randomized comparative study.
Neurourol Urodyn. 2015 Apr 24. doi: 10.1002/nau.22780 -
Chen SF, Chueh SC, Wang SM, Wu VC, Pu YS, Wu KD, Huang KH Clinical outcomes in patients undergoing laparoscopic adrenalectomy for unilateral aldosterone producing adenoma: partial versus total adrenalectomy
J Endourol.2014 Sep;28(9):1103-6 -
Chen SF, Kuo HC Improvement in autonomic dysreflexia after detrusor onabotulinumtoxinA injections in patients with chronic spinal cord injuries
Tzu Chi Medical Journal, Vol. 24, Issue 4, p201–204
國際論文演講
- Sheng-Fu Chen, Hann-Chorng Kuo Effect of detrusor Botox injection on the urothelial dysfunction in chronic spinal cord injury bladders comparison among baseline, 3 months and 6 months (2014 EAU 歐洲泌尿科醫學會年會)
- Sheng-Fu Chen / Huai-Ching Tai / Hong-Jeng Yu / Shih-Ping Liu; Yeong-Shiau Pu Are Lower Urinary Tract Symptoms in Women with Type 2 Diabetes Affected by Glycemic Control (2013 AUA 美國泌尿科醫學會年會)
- Sheng-Fu Chen, Hann-Chorng Kuo Improvement in autonomic dysreflexia after detrusor onabotulinumtoxinA injections in patients with chronic spinal cord injuries (2013 AUA 美國泌尿科醫學會年會)
- Sheng-Fu Chen, Hann-Chorng Kuo lack of consistent therapeutic effects of repeated 200 u onabotulinumtoxina detrusor injections on urinary incontinence in chronic spinal cord injured patients (2012 aua 美國泌尿科醫學會年會)
